Emcure Pharmaceuticals bags Merit Award at HIV Congress 2023
The Award acknowledges Emcure's contribution in the field of HIV/AIDS to improve the quality of life of people living with HIV/AIDS.
The Award acknowledges Emcure's contribution in the field of HIV/AIDS to improve the quality of life of people living with HIV/AIDS.
Pharma major reports FY26 revenue of Rs 9,204 crore with 16.6% growth
The dispute stems from an earlier circular by Zuventus allegedly accusing Zorvia of market sabotage
With more than two decades of experience, he brings deep expertise in sales, marketing, business transformation, and strategic leadership
The price revision, effective April 3, 2026, brings the innovator molecule within the reach of a significantly larger patient base across the country
Emcure to distribute Roche's kidney transplant and anemia drugs in India
Emcure becomes the first Indian company to exclusively distribute and commercialise Poviztra, a second brand of Novo Nordisk’s Semaglutide injection for weight management
The transaction is expected to close in Q2 FY 2026
PRX-PLUS has a unique product feature with its deep-impacting formula
Subscribe To Our Newsletter & Stay Updated